189 related articles for article (PubMed ID: 21901119)
21. Loss of p27 expression and microsatellite instability in sporadic colorectal cancer.
Sarli L; Bottarelli L; Azzoni C; Campanini N; Di Cola G; Barilli AL; Marchesi F; Mazzeo A; Salvemini C; Morari S; Di Mauro D; Donadei E; Necchi F; Roncoroni L; Bordi C
Surg Oncol; 2006 Aug; 15(2):97-106. PubMed ID: 17123889
[TBL] [Abstract][Full Text] [Related]
22. Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer.
Bettstetter M; Woenckhaus M; Wild PJ; Rümmele P; Blaszyk H; Hartmann A; Hofstädter F; Dietmaier W
J Pathol; 2005 Apr; 205(5):606-14. PubMed ID: 15714592
[TBL] [Abstract][Full Text] [Related]
23. Clinical Impact of Mismatch Repair Protein Testing on Outcome of Early Staged Colorectal Carcinomas.
Gandhi JS; Goswami M; Sharma A; Tanwar P; Gupta G; Gupta N; Pasricha S; Mehta A; Singh S; Agarwal M; Gupta N
J Gastrointest Cancer; 2018 Dec; 49(4):406-414. PubMed ID: 28585041
[TBL] [Abstract][Full Text] [Related]
24. Value of the identification of microsatellite instability in colorectal cancer.
Barrasa Shaw A; López-Guerrero JA; Calatrava Fons A; García-Casado Z; Alapont Olavarrieta V; Campos Máñez J; Vázquez Albaladejo C
Clin Transl Oncol; 2009 Jul; 11(7):465-9. PubMed ID: 19574205
[TBL] [Abstract][Full Text] [Related]
25. [Relationship between microsatellite instability and hepatocyte growth factor expression and their prognostic significance in colorectal cancer].
Yang G; Zheng HX; Wu LN; Wan HL; Li N; Yang GC; Liang JF
Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):283-8. PubMed ID: 27087375
[TBL] [Abstract][Full Text] [Related]
26. Microsatellite instability in a population of sporadic colorectal cancers: correlation between genetic and pathological profiles.
Luceri C; De Filippo C; Guglielmi F; Caderni G; Messerini L; Biggeri A; Mini E; Tonelli F; Cianchi F; Dolara P
Dig Liver Dis; 2002 Aug; 34(8):553-9. PubMed ID: 12502211
[TBL] [Abstract][Full Text] [Related]
27. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability.
Hawkins N; Norrie M; Cheong K; Mokany E; Ku SL; Meagher A; O'Connor T; Ward R
Gastroenterology; 2002 May; 122(5):1376-87. PubMed ID: 11984524
[TBL] [Abstract][Full Text] [Related]
28. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
[TBL] [Abstract][Full Text] [Related]
29. Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer.
Carethers JM; Smith EJ; Behling CA; Nguyen L; Tajima A; Doctolero RT; Cabrera BL; Goel A; Arnold CA; Miyai K; Boland CR
Gastroenterology; 2004 Feb; 126(2):394-401. PubMed ID: 14762775
[TBL] [Abstract][Full Text] [Related]
30. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.
Koi M; Garcia M; Choi C; Kim HR; Koike J; Hemmi H; Nagasaka T; Okugawa Y; Toiyama Y; Kitajima T; Imaoka H; Kusunoki M; Chen YH; Mukherjee B; Boland CR; Carethers JM
Gastroenterology; 2016 Apr; 150(4):944-55. PubMed ID: 26752111
[TBL] [Abstract][Full Text] [Related]
31. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625
[TBL] [Abstract][Full Text] [Related]
32. Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapy.
Brueckl WM; Moesch C; Brabletz T; Koebnick C; Riedel C; Jung A; Merkel S; Schaber S; Boxberger F; Kirchner T; Hohenberger W; Hahn EG; Wein A
Anticancer Res; 2003; 23(2C):1773-7. PubMed ID: 12820457
[TBL] [Abstract][Full Text] [Related]
33. High microsatellite instability (MSI-H) is associated with distinct clinical and molecular characteristics and an improved survival in early Colon cancer (CC); real world data from the AIO molecular registry Colopredict Plus.
Noepel-Duennebacke S; Juette H; Feder IS; Kluxen L; Basara N; Hiller W; Herzog T; Klaassen-Mielke R; Mueller L; Senkal M; Engel L; Teschendorf C; Trenn G; Verdoodt B; Wolters H; Uhl W; Reinacher-Schick A; Tannapfel A
Z Gastroenterol; 2020 Jun; 58(6):533-541. PubMed ID: 32544965
[TBL] [Abstract][Full Text] [Related]
34. CDX2 Loss With Microsatellite Stable Phenotype Predicts Poor Clinical Outcome in Stage II Colorectal Carcinoma.
Slik K; Turkki R; Carpén O; Kurki S; Korkeila E; Sundström J; Pellinen T
Am J Surg Pathol; 2019 Nov; 43(11):1473-1482. PubMed ID: 31490234
[TBL] [Abstract][Full Text] [Related]
35. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer.
Nodin B; Johannesson H; Wangefjord S; O'Connor DP; Lindquist KE; Uhlén M; Jirström K; Eberhard J
Diagn Pathol; 2012 Aug; 7():115. PubMed ID: 22935204
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer.
Wright CM; Dent OF; Barker M; Newland RC; Chapuis PH; Bokey EL; Young JP; Leggett BA; Jass JR; Macdonald GA
Br J Surg; 2000 Sep; 87(9):1197-202. PubMed ID: 10971428
[TBL] [Abstract][Full Text] [Related]
37. Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer.
Mohan HM; Ryan E; Balasubramanian I; Kennelly R; Geraghty R; Sclafani F; Fennelly D; McDermott R; Ryan EJ; O'Donoghue D; Hyland JM; Martin ST; O'Connell PR; Gibbons D; Winter D; Sheahan K
Eur J Surg Oncol; 2016 Nov; 42(11):1680-1686. PubMed ID: 27370895
[TBL] [Abstract][Full Text] [Related]
38. CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer.
Cleven AH; Derks S; Draht MX; Smits KM; Melotte V; Van Neste L; Tournier B; Jooste V; Chapusot C; Weijenberg MP; Herman JG; de Bruïne AP; van Engeland M
Clin Cancer Res; 2014 Jun; 20(12):3261-71. PubMed ID: 24928946
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients.
Lanza G; Gafà R; Santini A; Maestri I; Guerzoni L; Cavazzini L
J Clin Oncol; 2006 May; 24(15):2359-67. PubMed ID: 16710035
[TBL] [Abstract][Full Text] [Related]
40. The Association Between Mutations in BRAF and Colorectal Cancer-Specific Survival Depends on Microsatellite Status and Tumor Stage.
Bläker H; Alwers E; Arnold A; Herpel E; Tagscherer KE; Roth W; Jansen L; Walter V; Kloor M; Chang-Claude J; Brenner H; Hoffmeister M
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):455-462.e6. PubMed ID: 29660527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]